Zolsketil pegylated liposomal doxorubicin

doxorubicin hydrochloride, liposomal · Accord Healthcare S.L.U.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zolsketil pegylated liposomal doxorubicin, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: EMA Authorised: Zolsketil pegylated liposomal (doxorubicin hydrochloride, liposomal) — Accord Healthcare S.L.U.